Successful use of cyclophosphamide, bortezomib, and dexamethasone to treat a case of relapsed POEMS

Rahma Warsame, Ingrid E. Kohut, Angela Dispenzieri

Research output: Contribution to journalArticle

24 Scopus citations

Abstract

POEMS syndrome is a rare paraneoplastic condition related to myeloma. Because it is rare, there is very little known about treatment options. The use of potentially neurotoxic chemotherapeutic drugs is of concern in a disease whose major manifestation is neuropathy. Herein, we describe an extraordinary response to the combination of cyclophosphamide, bortezomib, and dexamethasone (CyBorD) in a patient with relapsed, life-threatening POEMS syndrome.

Original languageEnglish (US)
Pages (from-to)549-550
Number of pages2
JournalEuropean Journal of Haematology
Volume88
Issue number6
DOIs
StatePublished - Jun 1 2012

Keywords

  • POEMS
  • Treatment

ASJC Scopus subject areas

  • Hematology

Fingerprint Dive into the research topics of 'Successful use of cyclophosphamide, bortezomib, and dexamethasone to treat a case of relapsed POEMS'. Together they form a unique fingerprint.

  • Cite this